Devices

|

26

FDA Grants Breakthrough Device Designation to AI-Enabled Diagnostic for Kidney Disease

Renalytix AI, a company developing of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that it has been granted …

|

Study: Diabetes Management Apps May Not Be The Panacea to Glucose Management

You may be a little overwhelmed by all the new diabetes management apps out there. Well, you’re not alone. Now, a new study from Singapore …

|

LifeScan OneTouch Verio Reflect(TM) System Coming Soon to Canada

LifeScan Inc., a leader in blood glucose monitoring, recently announced the new OneTouch Verio Reflect™ system received Health Canada’s …

Companion Medical’s InPen System Available in Retail Pharmacies Nationwide

Companion Medical announced last week it’s expanding access to its InPen™ System which will now be available in retail pharmacies …

LifeScan, Inc. Introduces the OneTouch Reveal® Plus Mobile App in Canada

LifeScan, Inc. recently introduced the OneTouch Reveal® Plus mobile app, which has received a Health Canada license. It will soon be available to …

Can a Genetic Test Predict Your Chances of Developing Type 2 Diabetes?

Diabetes is a global pandemic. One in 11 adults has diabetes and in 2040, 1 in 10 adults will have diabetes. It is one of the most important global …

| |

App uses smartphone camera, flashlight to detect diabetes

Type 2 diabetes is among the strongest risk factors for heart disease, yet up to 1 in 3 people living with diabetes don’t know they have it and …

Glooko Mobile App Now Free For All People with Diabetes

Glooko, a company focused on diabetes management says its mobile app available for both Android and iOS, will now be available for free for any …

Senseonics Eversense® CGM Integrates with Glooko Diabetes Management Platform

Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform. Senseonics is focused on …

|

Abbott and Novo Nordisk Partner to Provide Digital Solution for Those Using Insulin

Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens. …

|